DESIGN AND DEVELOPMENT OF ANTI-INFLAMMATORY DRUG NAPROXEN SOLID DISPERSIONS AND FORMULATIONS BY FACTORIAL DESIGN APPROACH

Suranaree Journal of Science and Technology Pub Date : 2024-02-05 DOI:10.55766/sujst-2023-06-e01216

Taraka Ramarao Challa, Pathivada SaiKiranmai

{"title":"DESIGN AND DEVELOPMENT OF ANTI-INFLAMMATORY DRUG NAPROXEN SOLID DISPERSIONS AND FORMULATIONS BY FACTORIAL DESIGN APPROACH","authors":"Taraka Ramarao Challa, Pathivada SaiKiranmai","doi":"10.55766/sujst-2023-06-e01216","DOIUrl":null,"url":null,"abstract":"Naproxen is a non-steroidal anti-inflammatory (NSAID) drug that can be used as an analgesic, anti-inflammatory, and antipyretic. Objectives: The study’s major goal was to improve the drug’s solubility and dissolution rate, as well as its oral bioavailability. Methods: Physical mixture, kneading process, and solvent evaporation method were used to make Naproxen solid dispersions (SDs). Using a two-level factorial design and three independent components, X1 β-Cyclodextrin, X2: Kolliphor p-188, and X3: PVPK-30 and designed by a Design expert (DOE). The formulation was studied by flow parameters, physical characteristics, Fourier-transform infrared spectroscopy, and comparative investigations with commercially available Naprosyn and F2. Major Results: In vitro performance of solid dispersions SD’s was favorable (100% drug release 20 minutes), compared to a pure drug, where 100 percent drug release takes 80 minutes. The FTIR spectra of pure drug and combinations with excipients were having no chemical interaction. The F44<F88<F77<F11<F66<F55<F33<F2 depicts the order of released various formulations. The release profiles of F2 and the Naprosyn tablet are similar. These findings suggest that a new naproxen tablet formulation, including the β-Cyclodextrin: Kolliphor - p188 complex, could be a viable alternative for improving oral bioavailability.","PeriodicalId":509211,"journal":{"name":"Suranaree Journal of Science and Technology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Suranaree Journal of Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55766/sujst-2023-06-e01216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Naproxen is a non-steroidal anti-inflammatory (NSAID) drug that can be used as an analgesic, anti-inflammatory, and antipyretic. Objectives: The study’s major goal was to improve the drug’s solubility and dissolution rate, as well as its oral bioavailability. Methods: Physical mixture, kneading process, and solvent evaporation method were used to make Naproxen solid dispersions (SDs). Using a two-level factorial design and three independent components, X1 β-Cyclodextrin, X2: Kolliphor p-188, and X3: PVPK-30 and designed by a Design expert (DOE). The formulation was studied by flow parameters, physical characteristics, Fourier-transform infrared spectroscopy, and comparative investigations with commercially available Naprosyn and F2. Major Results: In vitro performance of solid dispersions SD’s was favorable (100% drug release 20 minutes), compared to a pure drug, where 100 percent drug release takes 80 minutes. The FTIR spectra of pure drug and combinations with excipients were having no chemical interaction. The F44

查看原文本刊更多论文

用因子设计法设计和开发消炎药萘普生的固体分散体和制剂

萘普生是一种非甾体抗炎药（NSAID），可用作镇痛、消炎和解热剂。研究目的研究的主要目标是提高药物的溶解度和溶解速率，以及口服生物利用度。研究方法采用物理混合法、捏合法和溶剂蒸发法制备萘普生固体分散体（SDs）。采用两级因子设计和三个独立组分，即 X1 β-环糊精、X2：Kolliphor p-188 和 X3：PVPK-30，并由设计专家（DOE）进行设计。通过流动参数、物理特性、傅立叶变换红外光谱以及与市售 Naprosyn 和 F2 的对比研究，对配方进行了研究。主要结果：与纯药物相比，固体分散体 SD 的体外性能良好（20 分钟内 100%释放药物），而纯药物需要 80 分钟才能 100%释放药物。纯药物和辅料组合的傅立叶变换红外光谱没有化学作用。F44

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Suranaree Journal of Science and Technology

自引率

0.00%

发文量

京公网安备 11010802042870号

Book学术文献互助群
群号：481959085